Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

ZBH · NYSE · Healthcare / Medical Devices

103.21USD-1.35 (-1.29%)

Price History

Full chart

Market Stats

Previous Close104.56
Open105.61
Day Range102.88 – 105.61
52-Week Range78.70 – 105.75
Volume2.52M
Market Cap17.42B
P/E (TTM)22.17
Forward P/E10.05
EPS4.12
Dividend Yield1.05%
Beta0.47
50-Day Avg96.12
200-Day Avg91.39

About

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Ivan Tornos
  • Employees17.00K
  • Headquarters345 East Main Street, Warsaw, IN, United States, 46580, USA
  • Websitehttps://www.zimmerbiomet.com

Leadership

  • Mr. Ivan TornosPresident, CEO & Chairman of the Board · b. 1975
  • Mr. Wilfred van ZuilenGroup President of Europe, Middle East & Africa · b. 1970
  • Mr. JehanZeb NoorSenior VP, Chief Strategy, Business Development, Innovation & Transformation Officer · b. 1982
  • Mr. Paul A. StellatoInterim CFO, VP, Controller & Chief Accounting Officer · b. 1975
  • Mr. Shaun BraunSenior VP & Chief Information and Technology Officer
  • Dr. Jonathan M. Vigdorchik M.D.Chief Science, Technology & Medical Affairs Officer
  • Mr. David M. DeMartinoSenior Vice President of Investor Relations
  • Mr. Chad F. Phipps J.D.Senior VP, Chief Legal & Corporate Affairs Officer and Secretary · b. 1972
  • Ms. Angela MainSenior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific
  • Ms. Kristen CardilloSenior VP & Chief Communications Officer

Financials

Income Statement

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue861.00M939.00M1.04B1.18B1.37B1.90B2.98B3.29B3.50B3.90B4.12B4.10B4.22B4.45B4.47B4.62B4.67B6.00B7.67B7.80B7.93B7.98B6.13B6.83B6.94B7.39B7.68B8.23B
Growth (%)-+9.06%+10.82%+13.26%+16.44%+38.52%+56.81%+10.24%+6.37%+11.50%+5.74%-0.62%+3.05%+5.49%+0.45%+3.39%+1.08%+28.34%+27.85%+1.76%+1.66%+0.62%-23.24%+11.42%+1.65%+6.55%+3.85%+7.20%
Cost of Revenue265.00M269.00M290.90M325.90M344.80M516.20M779.90M739.40M780.10M875.90M997.30M990.70M1.01B1.12B1.13B1.29B1.24B1.80B2.38B2.13B2.27B2.25B1.82B1.96B2.02B2.08B2.19B3.16B
Gross Profit596.00M670.00M749.70M852.70M1.03B1.38B2.20B2.55B2.72B3.02B3.12B3.10B3.21B3.33B3.35B3.34B3.43B4.20B5.29B5.67B5.66B5.73B4.30B4.87B4.92B5.31B5.49B5.07B
Gross Margin69.22%71.35%72.04%72.35%74.88%72.85%73.84%77.50%77.68%77.53%75.80%75.81%76.02%74.80%74.84%72.18%73.41%69.98%68.94%72.67%71.36%71.78%70.23%71.29%70.90%71.82%71.46%61.62%
Operating Expense385.00M439.00M481.70M604.40M626.70M934.10M1.44B1.49B1.55B1.89B2.03B2.09B2.29B2.31B2.30B2.30B2.39B3.73B4.47B4.87B5.63B4.59B4.22B4.01B4.22B4.03B4.20B3.71B
Operating Income211.00M231.00M268.00M248.30M400.90M450.70M763.20M1.05B1.17B1.13B1.09B1.02B916.70M1.02B1.05B1.04B1.04B467.30M821.10M799.30M33.80M1.14B83.10M860.30M696.30M1.28B1.29B1.36B
Operating Margin24.51%24.60%25.75%21.07%29.21%23.71%25.60%32.10%33.34%28.93%26.45%24.88%21.72%23.00%23.42%22.40%22.20%7.79%10.71%10.24%0.43%14.25%1.36%12.60%10.03%17.28%16.74%16.55%
EBITDA237.00M253.00M291.10M271.70M426.20M644.80M1.03B1.30B1.37B1.38B1.43B1.47B1.26B1.39B1.43B1.41B1.38B1.15B1.79B1.85B1.06B2.14B1.01B1.65B1.49B2.22B2.25B2.22B
EBITDA Margin27.53%26.94%27.97%23.05%31.06%33.92%34.41%39.48%39.16%35.48%34.79%35.95%29.87%31.32%31.89%30.49%29.49%19.21%23.39%23.74%13.35%26.79%16.41%24.10%21.54%30.03%29.31%26.94%
Net Income145.00M150.00M176.00M149.80M257.80M346.30M541.80M732.50M834.50M773.20M848.60M717.40M596.90M760.80M755.00M761.00M720.30M147.00M305.90M1.81B-379.20M1.13B-138.90M401.60M231.40M1.02B903.80M705.20M
Net Income Margin16.84%15.97%16.91%12.71%18.78%18.22%18.18%22.29%23.87%19.84%20.59%17.52%14.14%17.09%16.88%16.46%15.41%2.45%3.99%23.24%-4.78%14.18%-2.27%5.88%3.33%13.85%11.77%8.57%
R&D36.00M45.00M52.00M71.60M80.70M105.80M166.70M175.50M188.30M209.60M192.30M205.70M218.50M238.40M225.60M204.20M191.90M268.80M365.60M369.90M391.70M449.30M322.80M435.80M406.00M458.70M437.40M458.50M
R&D as % of Total Revenue4.18%4.79%5.00%6.08%5.88%5.57%5.59%5.34%5.39%5.38%4.67%5.02%5.18%5.36%5.05%4.42%4.11%4.48%4.77%4.74%4.94%5.63%5.27%6.38%5.85%6.20%5.70%5.57%
Interest Expense0007.40M12.00M139.20M194.00M128.40M8.90M216.40M31.80M20.60M60.20M55.30M72.90M70.10M63.10M286.60M355.00M325.30M289.30M226.90M212.10M208.40M164.80M201.20M218.00M292.80M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.63%0.87%7.32%6.51%3.91%0.25%5.55%0.77%0.50%1.43%1.24%1.63%1.52%1.35%4.78%4.63%4.17%3.65%2.84%3.46%3.05%2.37%2.72%2.84%3.56%

Balance Sheet

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-606.00M597.40M745.00M858.90M5.16B5.70B5.72B5.97B6.63B7.24B7.79B8.00B8.52B9.01B9.58B9.63B27.41B26.68B26.01B24.13B24.64B24.42B23.46B21.07B21.50B21.37B23.09B
Total Liabilities-215.00M336.40M666.30M492.60M2.01B1.75B1.04B1.05B1.18B1.59B2.15B2.23B3.00B3.15B3.28B3.11B17.59B17.01B14.28B12.85B12.25B12.22B10.79B9.04B9.01B8.89B10.39B
Total Equity-391.00M261.00M78.70M366.30M3.14B3.94B4.68B4.92B5.45B5.65B5.64B5.77B5.51B5.86B6.30B6.52B9.81B9.67B11.74B11.27B12.39B12.19B12.66B12.02B12.48B12.47B12.70B
Cash---18.40M15.70M77.50M154.60M233.20M265.70M463.90M212.60M691.70M668.90M768.30M884.30M1.08B1.08B1.45B634.10M524.40M542.80M617.90M802.10M378.10M375.70M415.80M525.50M591.90M
Total Debt---363.90M156.70M1.11B651.50M81.60M99.60M104.30M460.10M1.13B1.14B1.72B1.82B1.67B1.48B23.05B11.24B10.14B8.94B8.22B8.13B7.07B5.70B5.77B6.20B7.52B
Net Debt---345.50M141.00M1.03B496.90M-151.60M-166.10M-359.60M247.50M435.90M473.20M951.00M936.60M592.20M342.20M10.10B10.61B9.62B8.40B7.60B7.32B6.69B5.32B5.35B5.68B6.93B

Cash Flow

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow199.00M180.00M232.40M171.80M220.20M494.80M862.20M878.20M1.04B1.08B1.04B1.12B1.19B1.18B1.15B963.10M1.06B849.80M1.63B1.58B1.75B1.59B1.20B1.50B1.28B1.58B1.50B1.70B
Investing Cash Flow-20.00M-33.00M-29.00M-54.70M-35.70M-1.10B-388.30M-311.10M-287.00M-491.50M-924.20M-381.20M-726.90M-624.40M-592.10M-282.50M-469.40M-7.56B-1.69B-510.80M-416.60M-729.30M-613.80M-503.60M-529.20M-778.90M-888.10M-1.98B
Financing Cash Flow-179.00M-147.00M-203.40M-99.10M-188.90M664.80M-402.00M-484.60M-730.70M-399.50M-343.50M-262.10M-489.60M-455.80M-436.50M-467.30M-562.40M7.14B-743.20M-1.21B-1.30B-779.90M-421.80M-1.31B-843.80M-763.50M-484.50M326.00M
Capital Expenditure20.00M33.00M29.00M54.70M33.70M158.50M100.80M105.30M268.30M331.20M597.30M264.60M87.70M113.80M114.70M100.00M144.90M167.70M184.70M156.00M162.70M404.70M117.90M152.00M187.90M394.50M356.80M224.50M
Free Cash Flow179.00M147.00M203.40M117.10M186.50M336.30M761.40M772.90M772.40M753.20M440.80M852.90M1.11B1.06B1.04B863.10M915.60M682.10M1.45B1.43B1.58B1.18B1.09B1.35B1.10B1.19B1.14B1.47B
Dividends Paid---290.00M-------00510.40M94.40M132.40M145.50M157.10M188.40M193.60M195.20M196.70M198.50M200.10M201.20M200.90M196.00M190.30M
FCF to OCF89.95%81.67%87.52%68.16%84.70%67.97%88.31%88.01%74.22%69.46%42.46%76.32%92.65%90.33%90.04%89.62%86.34%80.27%88.68%90.14%90.69%74.48%90.21%89.86%85.37%75.06%76.20%86.77%
Dividend Paid to FCF---247.65%-------0.00%0.00%48.01%9.10%15.34%15.89%23.03%13.02%13.57%12.32%16.65%18.27%14.85%18.34%16.92%17.15%12.92%

Earnings

Report DateAug 29, 2001Oct 30, 2001Feb 4, 2002Apr 24, 2002Jul 24, 2002Oct 21, 2002Jan 29, 2003Apr 23, 2003Jul 23, 2003Oct 22, 2003Feb 9, 2004Apr 26, 2004Jul 28, 2004Oct 25, 2004Jan 31, 2005Apr 25, 2005Jul 27, 2005Oct 26, 2005Jan 30, 2006Apr 26, 2006Jul 26, 2006Oct 25, 2006Jan 29, 2007Apr 25, 2007Jul 25, 2007Oct 24, 2007Jan 29, 2008Apr 24, 2008Jul 22, 2008Oct 23, 2008Jan 29, 2009Apr 23, 2009Jul 23, 2009Oct 22, 2009Jan 28, 2010Apr 22, 2010Jul 22, 2010Oct 28, 2010Jan 27, 2011Apr 28, 2011Jul 27, 2011Oct 27, 2011Jan 26, 2012Apr 26, 2012Jul 26, 2012Oct 25, 2012Jan 31, 2013Apr 25, 2013Jul 25, 2013Oct 24, 2013Jan 30, 2014Apr 24, 2014Jul 24, 2014Oct 23, 2014Jan 29, 2015Apr 30, 2015Jul 30, 2015Oct 29, 2015Jan 28, 2016Apr 28, 2016Jul 28, 2016Oct 31, 2016Jan 31, 2017Apr 27, 2017Jul 27, 2017Nov 1, 2017Jan 30, 2018Apr 26, 2018Jul 27, 2018Oct 26, 2018Feb 1, 2019Apr 26, 2019Jul 26, 2019Nov 5, 2019Feb 4, 2020May 11, 2020Aug 4, 2020Nov 6, 2020Feb 5, 2021May 4, 2021Aug 3, 2021Nov 4, 2021Feb 7, 2022May 3, 2022Aug 2, 2022Nov 2, 2022Feb 3, 2023May 2, 2023Aug 1, 2023Nov 7, 2023Feb 8, 2024May 2, 2024Aug 7, 2024Oct 30, 2024Feb 6, 2025May 5, 2025Aug 7, 2025Nov 5, 2025Feb 10, 2026Apr 28, 2026Aug 5, 2026Nov 4, 2026
EPS Estimate-0.230.260.250.300.300.340.380.420.410.470.510.550.530.640.670.750.670.830.820.820.750.990.930.980.911.041.041.030.881.000.940.960.861.081.021.050.991.191.121.191.031.341.301.321.131.491.401.441.241.621.471.491.301.701.581.561.562.041.931.971.792.112.112.101.742.101.891.891.602.171.861.911.752.271.47-0.631.082.061.531.861.761.981.421.641.561.831.641.811.602.161.871.991.742.291.771.981.882.401.862.011.89
EPS Actual0.220.250.270.280.340.330.370.390.450.430.510.560.580.560.710.750.800.700.860.820.830.761.020.980.980.911.181.041.030.891.000.951.000.881.121.021.090.961.271.191.211.041.361.301.341.151.511.411.431.251.661.501.491.351.711.581.591.642.092.002.021.792.142.132.081.722.101.911.921.632.181.871.931.772.301.700.051.812.111.711.901.811.951.611.821.581.881.891.821.652.201.942.011.742.311.812.071.902.422.092.07-
Surprise-8.70%3.85%12.00%13.33%10.00%8.82%2.63%7.14%4.88%8.51%9.80%5.45%5.66%10.94%11.94%6.67%4.48%3.61%0.00%1.22%1.33%3.03%5.38%0.00%0.00%13.46%0.00%0.00%1.14%0.00%1.06%4.17%2.33%3.70%0.00%3.81%-3.03%6.72%6.25%1.68%0.97%1.49%0.00%1.52%1.77%1.34%0.71%-0.69%0.81%2.47%2.04%0.00%3.85%0.59%0.00%1.92%5.13%2.45%3.63%2.54%0.00%1.42%0.95%-0.95%-1.15%0.00%1.06%1.59%1.88%0.46%0.54%1.05%1.14%1.32%15.65%107.94%67.59%2.43%11.76%2.15%2.84%-1.52%13.38%10.98%1.28%2.73%15.24%0.55%3.13%1.85%3.74%1.00%0.00%0.87%2.26%4.55%1.06%0.83%12.37%2.99%-
Timing-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap17.42B
Enterprise Value24.40B
Trailing P/E22.17
Forward P/E10.05
PEG Ratio0.57
Price / Sales2.05
Price / Book1.37
EPS4.12
Book Value66.23
Revenue (TTM)8.51B
Gross Profit (TTM)5.92B
EBITDA2.52B
Profit Margin9.48%
Operating Margin17.96%
Return on Equity6.41%
Return on Assets3.88%
Shares Outstanding190.74M
Shares Float190.13M
Beta0.47
Dividend Yield1.05%
Dividend Rate0.96
Payout Ratio11.32%

Analyst Ratings

Hold
Based on 29 analystsTarget 107.57
  • Strong Buy
    5
  • Buy
    6
  • Hold
    16
  • Sell
    1
  • Strong Sell
    1

Ownership Breakdown

Institutions
111.37%
Insiders
0.16%
Retail / Other
0.00%

Top Institutional Holders

  • Dodge & Cox
    24.12M12.65%
  • BlackRock Inc
    15.34M8.04%
  • Vanguard Capital Management, LLC
    12.79M6.71%
  • Harris Associates L.P.
    12.74M6.68%
  • Capital Research & Mgmt Co - Division 3
    12.18M6.39%
  • State Street Corp
    8.83M4.63%
  • Vanguard Portfolio Management, LLC
    8.65M4.54%
  • T. Rowe Price Associates, Inc.
    8.00M4.19%
  • Franklin Templeton Inc
    5.45M2.86%
  • Geode Capital Management, LLC
    5.38M2.82%
  • PRIMECAP Management Company
    3.82M2.00%
  • Van Eck Associates Corporation
    3.76M1.97%
  • Amvescap Plc.
    3.61M1.89%

Top Fund Holders

  • Dodge & Cox Stock I
    15.55M8.15%
  • Vanguard MStar Total Stk Mkt Idx Invest
    6.15M3.22%
  • Vanguard Windsor II Inv
    5.87M3.08%
  • Oakmark Investor
    5.62M2.95%
  • Vanguard 500 Index Investor
    5.14M2.69%
  • American Funds Washington Mutual A
    4.93M2.59%
  • American Funds Growth Fd of Amer A
    3.74M1.96%

Dividends

20263×
0.24Sep 30, 20260.24Jun 25, 20260.24Mar 31, 2026
20254×
0.24Dec 30, 20250.24Sep 30, 20250.24Jun 26, 20250.24Mar 31, 2025
20244×
0.24Dec 30, 20240.24Sep 30, 20240.24Jun 26, 20240.24Mar 27, 2024
20234×
0.24Dec 26, 20230.24Sep 28, 20230.24Jun 23, 20230.24Mar 28, 2023
20224×
0.24Dec 23, 20220.24Sep 29, 20220.24Jun 24, 20220.24Mar 28, 2022
20214×
0.23Dec 27, 20210.23Sep 29, 20210.23Jun 25, 20210.23Mar 26, 2021
20201×
0.23Dec 24, 2020

Stock Splits

  • Mar 1, 2022103:100